Durham, North Carolina, United States The Aurora Funds is the famous VC, which was founded in 1994. The company was established in North America in United States. The main office of represented VC is situated in the Durham.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Cardioxyl Pharmaceuticals, Opsware, Blackboard. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Medical Device, Pharmaceutical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the The Aurora Funds, startups are often financed by The Trelys Funds, Intersouth Partners, Sevin Rosen Funds. The meaningful sponsors for the fund in investment in the same round are Novak Biddle Venture Partners, Harbert Growth Partners, 180 Degree Capital. In the next rounds fund is usually obtained by 180 Degree Capital, Sevin Rosen Funds, Intersouth Partners.
The fund was created by Jeff Clark. Besides them, we counted 3 critical employees of this fund in our database.
The fund is constantly included in 2-6 deals per year. The high activity for fund was in 2000. Comparing to the other companies, this The Aurora Funds performs on 3 percentage points less the average number of lead investments. The top amount of exits for fund were in 2018. When the investment is from The Aurora Funds the average startup value is 10-50 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alida Capital International | - |
| Brand New Brands | California, Mill Valley, United States |
| Bregal Sagemount | New York, New York, United States |
| CunCunLe | Beijing, China, Mentougou |
| Fortistar | New York, United States, White Plains |
| Hennepin Healthcare | Minneapolis, Minnesota, United States |
| Hongkai Investment | China, Shanghai |
| Jiuan Fuying Investment | China, Guangdong, Shenzhen |
| Jun Joint Venture | - |
| KittyHawk Ventures | California, Los Angeles, United States |
| Lee Munder Venture | Boston, Massachusetts, United States |
| Nonami Investments | Atlanta, Georgia, United States |
| Private Life Biomed | Germany, Hamburg |
| Qianshu Capital | Beijing, Beijing, China |
| Qingrongxin | China, Guangdong, Shenzhen |
| rocketship.vc | California, Los Altos, United States |
| State Of Texas' Emerging Technology Fund | - |
| Stone System | Japan, Tokyo |
| White Sheep Capital, inc | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cardioxyl Pharmaceuticals | $28M | 13 Nov 2012 | North Carolina, United States | ||
Digitalsmiths | $12M | 27 Apr 2011 | Durham, North Carolina, United States | ||
CardioFocus | $30M | 28 Feb 2011 | Marlborough, Massachusetts, United States | ||
Centice | $6M | 17 Jan 2010 | North Carolina, United States | ||
Metabolon | $6M | 07 Dec 2009 | Durham, North Carolina, United States | ||
Metabolon | $6M | 27 Oct 2009 | Durham, North Carolina, United States | ||
Digitalsmiths | $12M | 13 Nov 2008 | Durham, North Carolina, United States | ||
Unitrends | $9M | 30 Apr 2008 | Massachusetts, United States | ||
Centice | $11M | 19 Nov 2007 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cardioxyl Pharmaceuticals | $28M | 13 Nov 2012 | North Carolina, United States | ||
Digitalsmiths | $12M | 27 Apr 2011 | Durham, North Carolina, United States | ||
CardioFocus | $30M | 28 Feb 2011 | Marlborough, Massachusetts, United States | ||
Centice | $6M | 17 Jan 2010 | North Carolina, United States | ||
Metabolon | $6M | 07 Dec 2009 | Durham, North Carolina, United States | ||
Metabolon | $6M | 27 Oct 2009 | Durham, North Carolina, United States | ||
Digitalsmiths | $12M | 13 Nov 2008 | Durham, North Carolina, United States | ||
Unitrends | $9M | 30 Apr 2008 | Massachusetts, United States | ||
Centice | $11M | 19 Nov 2007 | North Carolina, United States |
